BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6340194)

  • 21. Oral medications affecting blood coagulation.
    Kloch SM; Kloch GM
    Plast Surg Nurs; 1984; 4(2):52-5. PubMed ID: 6565289
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemical induction of fibrinolysis and inhibition of platelet aggregation (with special respect to effect of nonsteroid antiinflammatory drugs).
    Cepelák V; Roubal Z; Cepeláková H; Nĕmecek O
    Acta Univ Carol Med Monogr; 1972; 52():41-7. PubMed ID: 4669825
    [No Abstract]   [Full Text] [Related]  

  • 23. [Peripherally acting analgesics during treatment with oral anticoagulants].
    Boeijinga JK; Heijdanus PB; Hoogslag MA
    Ned Tijdschr Geneeskd; 1982 Mar; 126(13):579-84. PubMed ID: 6978466
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.
    MacLeod SM; Sellers EM
    Drugs; 1976; 11(6):461-70. PubMed ID: 782840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Direct oral anticoagulants: efficacy and safety in patient subgroups.
    Mavrakanas TA; Samer C; Fontana P; Perrier A
    Swiss Med Wkly; 2015; 145():w14081. PubMed ID: 25658756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of indirect anticoagulants].
    Niedner R; Meyer F
    Z Allgemeinmed; 1974 Nov; 50(32):1471-6. PubMed ID: 4139825
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
    Beinema M; Brouwers JR; Schalekamp T; Wilffert B
    Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Misleading results in studying pharmacodynamic interaction with oral anticoagulants.
    de Feo G; Lisciani R; Del Vecchio A; Orticelli G; Valeri P; Noli G; Mazzanti G
    Boll Chim Farm; 1990 Apr; 129(4):166-8. PubMed ID: 2245005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interaction problems in the therapy with steroid-free anti-rheumatics].
    Husmann F
    Fortschr Med; 1981 Aug; 99(31-32):1231-5. PubMed ID: 7274937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Interactions between glucocorticoids and warfarin in chronic inflammatory (autoimmune) diseases].
    Hromádková L; Vlček J
    Vnitr Lek; 2012 May; 58(5):354-6. PubMed ID: 22716170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of several coumarin compounds with human and canine plasma albumin.
    O'Reilly RA
    Mol Pharmacol; 1971 Mar; 7(2):209-18. PubMed ID: 5125855
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanism of action of vitamin K and how it is affected by anticoagulants].
    Schade R; Janowski K
    Pharmazie; 1976; 31(9):585-9. PubMed ID: 798207
    [No Abstract]   [Full Text] [Related]  

  • 35. Oral anticoagulant drugs: pharmacokinetic aspects.
    Breckenridge A
    Semin Hematol; 1978 Jan; 15(1):19-26. PubMed ID: 341326
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal outcome of interaction between warfarin and a non-steroidal anti-inflammatory drug.
    Gabb GM
    Med J Aust; 1996 Jun; 164(11):700-1. PubMed ID: 8657040
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis of novel 3-carboxamide-benzocoumarin derivatives as orally active antithrombotic agents.
    Sashidhara KV; Kumar A; Kumar M; Singh S; Jain M; Dikshit M
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7034-40. PubMed ID: 22004722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin K and the oral anticoagulant drugs.
    O'Reilly RA
    Annu Rev Med; 1976; 27():245-61. PubMed ID: 779597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of oxaprozin on the steady-state anticoagulant activity of warfarin.
    Davis LJ; Kayser SR; Hubsher J; Williams RL
    Clin Pharm; 1984; 3(3):295-7. PubMed ID: 6734092
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements.
    Hickmott H; Wynne H; Kamali F
    Thromb Haemost; 2003 May; 89(5):949-50. PubMed ID: 12719797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.